For assessing COVID-19 vaccine efficacy. Goldsite Diagnostics offers both qualitative and quantitative detection solution for SARS-CoV-2 neutralizing antibody.
Measuring the neutralizing antibodies potency are expected to build a defense against SARS-CoV-2 spreading, complementing vaccines and nonpharmaceutical interventions.
For vaccine efficacy monitoring
Understanding the human body’s immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
For treatment options guiding
Potent nAbs that were more effective at neutralizing the virus have better clinical outcomes. Early administration of nAbs is vital to identify patient of severity risk as an aid to treatment.
MULTIPLE CLINICAL APPLICATIONS
Measuring the neutralizing antibodies potency are expected to build a defense against SARS-CoV-2 spreading, complementing vaccines and nonpharmaceutical interventions.
For vaccine efficacy monitoring
Understanding the human body’s immune response to SARS-CoV-2, the virus that causes COVID-19, is key to developing effective treatments and long-lasting vaccines.
For treatment options guiding
Potent nAbs that were more effective at neutralizing the virus have better clinical outcomes. Early administration of nAbs is vital to identify patient of severity risk as an aid to treatment.
Cost-effective, reproducible and time-saving
Only 10 mins for results.Suitable for large scale testing to
evaluate herd immunity in community
High sensitivity and specificity
Up to 100% positive agreement with gold standard VNT
Cost-effective, reproducible and time-saving
Only 10 mins for results.Suitable for large scale testing to
evaluate herd immunity in community
High sensitivity and specificity
Up to 100% positive agreement with gold standard VNT
*Product images are for illustrative purposes only and may differ from the actual product. Goldsite Diagnostics Inc. reserves the right to change the packaging design at anytime.
